Marketing as a Citizen of the Community

Education is the highest form of marketing. Shannon Maverick sets on out on a quest to speak with business leaders from around B2B to better understand how they are utilizing education with their customers.

 

Becoming a trusted source is key to marketing success.  When companies utilize community outreach as a cornerstone to marketing it fosters a strong, enduring, and mutually beneficial relationship.

Shannon Maverick, host of Maverick of Marketing, spoke with Joe Piccirrili on how to build trust with customers and clients in a digitally dominant world.

Joe Piccirrili is the Managing Director and CEO of RoseWater Energy Group.  He has a long history of entrepreneurship that began in the 1970s with the start of a stereo retail company.  In a marketing world that was focused on advertising price, Piccirrili concentrated his efforts on becoming a citizen of the community. This approach was incredibly successful and he repeated this tact again with a distribution company years later.

In 2012, Piccirrili saw the need for a reliable and stable power supply for microprocessors and other electronic equipment that are sensitive to power fluctuations.  RoseWater Energy Group was born and once again the marketing strategy was to build a community relationship and become a trusted resource.

Piccirrilli spoke about different ways to build this community trust and engagement.  He recommended talking to the press, getting on professional panels, community organizations, and participating in trade shows.

“It is extremely important,” said Piccirrili when it comes to becoming a citizen of the community. “It’s a long haul but i can think of nothing more valuable you can do because it creates synergy with all of your messages.”

Maverick and Piccirrili discussed how the technological transition has impacted marketing.  The COVID pandemic has accelerated an already existing trend of digital transformation.  Marketing in this remote manner is more difficult.  Demonstrating empathy, engaging audiences, being a good listener, and showing that you and your company are not self-serving is more of a challenge without in-person interactions.

They also spoke about strategies for marketing new products and mentoring new sales staff without face-to-face meetings.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More